PPA
BSTC

Parametric Portfolio Associates’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Parametric Portfolio Associates’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-21,582
Closed -$1.14M – 4057
2020
Q3 		$1.14M Sell
21,582
-4,979
-19% -$307K ﹤0.01% 2837
2020
Q2 		$1.63M Buy
26,561
+6,053
+30% +$350K ﹤0.01% 2625
2020
Q1 		$1.16M Sell
20,508
-8,241
-29% -$470K ﹤0.01% 2722
2019
Q4 		$1.64M Buy
28,749
+9,484
+49% +$503K ﹤0.01% 2819
2019
Q3 		$1.03M Sell
19,265
-12,539
-39% -$730K ﹤0.01% 3014
2019
Q2 		$1.9M Buy
31,804
+3,258
+11% +$205K ﹤0.01% 2703
2019
Q1 		$1.78M Buy
28,546
+13,275
+87% +$878K ﹤0.01% 2723
2018
Q4 		$925K Buy
15,271
+3,813
+33% +$228K ﹤0.01% 3034
2018
Q3 		$670K Sell
11,458
-510
-4% -$26K ﹤0.01% 3296
2018
Q2 		$537K Buy
11,968
+2,633
+28% +$113K ﹤0.01% 3314
2018
Q1 		$414K Buy
+9,335
New +$392K ﹤0.01% 3436

Other funds holding BSTC

UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Parametric Portfolio Associates's BSTC Position: Q4 2020 in Review

Parametric Portfolio Associates sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 21,582 shares — an estimated $1.14M sold.

Parametric Portfolio Associates first reported a position in BSTC in Q1 2018 and held it in 11 quarters. The position peaked at $1.9M in Q2 2019. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.

  • Parametric Portfolio Associates reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
  • Parametric Portfolio Associates sold 21,582 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $1.14M.
  • Parametric Portfolio Associates first reported a position in BioSpecifics Technologies Corp. in Q1 2018 and held it in 11 quarters.
  • Parametric Portfolio Associates's BioSpecifics Technologies Corp. position peaked at $1.9M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.

Based on Parametric Portfolio Associates's 13F filing for Q4 2020, filed 12 Feb 2021.